Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity

Necroptosis is a form of cell death associated with inflammation; however, the biological consequences of chronic necroptosis are unknown. Necroptosis is mediated by RIPK1, RIPK3, and MLKL kinases but in hematopoietic cells RIPK1 has anti-inflammatory roles and functions to prevent necroptosis. Here we interrogate the consequences of chronic necroptosis on immune homeostasis by deleting Ripk1 in mouse dendritic cells. We demonstrate that deregulated necroptosis results in systemic inflammation, tissue fibrosis, and autoimmunity. We show that inflammation and autoimmunity are prevented upon expression of kinase inactive RIPK1 or deletion of RIPK3 or MLKL. We provide evidence that the inflammation is not driven by microbial ligands, but depends on the release of danger-associated molecular patterns and MyD88-dependent signaling. Importantly, although the inflammation is independent of type I IFN and the nucleic acid sensing TLRs, blocking these pathways rescues the autoimmunity. These mouse genetic studies reveal that chronic necroptosis may underlie human fibrotic and autoimmune disorders.

[1]  David F. Boyd,et al.  DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death. , 2016, Cell host & microbe.

[2]  M. Pasparakis,et al.  RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation , 2016, Nature.

[3]  A. Strasser,et al.  RIPK1 inhibits ZBP1-driven necroptosis during development , 2016, Nature.

[4]  D. Green,et al.  The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis. , 2016, Immunity.

[5]  M. Kelliher,et al.  CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN. , 2016, Cell reports.

[6]  Matthew B. Dong,et al.  Flow cytometric gating for spleen monocyte and DC subsets: differences in autoimmune NOD mice and with acute inflammation. , 2016, Journal of immunological methods.

[7]  D. Vaux,et al.  In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-κB and activation of caspase-8. , 2016, The Journal of Biological Chemistry.

[8]  J. Silke,et al.  The diverse role of RIP kinases in necroptosis and inflammation , 2015, Nature Immunology.

[9]  C. Mohan,et al.  Suppression of systemic autoimmunity by the innate immune adaptor STING , 2015, Proceedings of the National Academy of Sciences.

[10]  P. Vandenabeele,et al.  Necroptosis and its role in inflammation , 2015, Nature.

[11]  N. Malhotra,et al.  The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair. , 2014, Immunity.

[12]  M. Pasparakis,et al.  Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis , 2014, Proceedings of the National Academy of Sciences.

[13]  M. Pasparakis,et al.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis , 2014, Nature.

[14]  M. Pasparakis,et al.  Cutting Edge: RIPK1 Kinase Inactive Mice Are Viable and Protected from TNF-Induced Necroptosis In Vivo , 2014, The Journal of Immunology.

[15]  A. Strasser,et al.  XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. , 2014, Cell reports.

[16]  D. Vaux,et al.  RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis , 2014, Cell.

[17]  D. Green,et al.  RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3 , 2014, Cell.

[18]  J. Bertin,et al.  RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition , 2014, Proceedings of the National Academy of Sciences.

[19]  L. Komuves,et al.  Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis , 2014, Science.

[20]  B. Croker,et al.  Pyroptotic death storms and cytopenia. , 2014, Current opinion in immunology.

[21]  S. Zanotti,et al.  Severe sepsis and septic shock , 2013, Virulence.

[22]  A. Strasser,et al.  The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. , 2013, Immunity.

[23]  J. Bertin,et al.  Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL* , 2013, The Journal of Biological Chemistry.

[24]  Daniel R. Caffrey,et al.  Overexpression of Membrane-Bound Fas Ligand (CD95L) Exacerbates Autoimmune Disease and Renal Pathology in Pristane-Induced Lupus , 2013, The Journal of Immunology.

[25]  A. Degterev,et al.  Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases , 2013, Proceedings of the National Academy of Sciences.

[26]  A. Winoto,et al.  Commensal microbiota are required for systemic inflammation triggered by necrotic dendritic cells. , 2013, Cell reports.

[27]  Wei Xu,et al.  DNA-dependent Activator of Interferon-regulatory Factors (DAI) Promotes Lupus Nephritis by Activating the Calcium Pathway* , 2013, The Journal of Biological Chemistry.

[28]  Peter Vandenabeele,et al.  Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. , 2013, Immunity.

[29]  Andrew Kovalenko,et al.  Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. , 2013, Immunity.

[30]  D. Vaux,et al.  TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1 , 2013, Cell Death and Disease.

[31]  R. Tibshirani,et al.  Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis , 2012, PloS one.

[32]  R. Korneluk,et al.  cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation , 2012, Cell Death and Differentiation.

[33]  Ji Luo,et al.  Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis , 2012, Proceedings of the National Academy of Sciences.

[34]  J. Tschopp,et al.  Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. , 2012, Immunity.

[35]  Xiaodong Wang,et al.  Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase , 2012, Cell.

[36]  Yuqiong Liang,et al.  Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3–mediated pathway , 2011, Proceedings of the National Academy of Sciences.

[37]  P. Marrack,et al.  Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c⁺ B-cell population is important for the development of autoimmunity. , 2011, Blood.

[38]  T. Wynn.  Integrating mechanisms of pulmonary fibrosis , 2011, The Journal of experimental medicine.

[39]  H. Wajant,et al.  SMAC Mimetic BV6 Induces Cell Death in Monocytes and Maturation of Monocyte-Derived Dendritic Cells , 2011, PloS one.

[40]  R. Hakem,et al.  RIP3 mediates the embryonic lethality of caspase-8-deficient mice , 2011, Nature.

[41]  D. Vaux,et al.  In TNF-stimulated Cells, RIPK1 Promotes Cell Survival by Stabilizing TRAF2 and cIAP1, which Limits Induction of Non-canonical NF-κB and Activation of Caspase-8* , 2011, The Journal of Biological Chemistry.

[42]  Zheng‐gang Liu,et al.  TNFα-induced noncanonical NF-κB activation is attenuated by RIP1 through stabilization of TRAF2 , 2011, Journal of Cell Science.

[43]  Guy S. Salvesen,et al.  Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis , 2011, Nature.

[44]  A. Fogo,et al.  Models of chronic kidney disease. , 2010, Drug discovery today. Disease models.

[45]  B. Beutler,et al.  Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus , 2009, Proceedings of the National Academy of Sciences.

[46]  Steffen Jung,et al.  Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. , 2008, Immunity.

[47]  Alexei Degterev,et al.  Identification of RIP1 kinase as a specific cellular target of necrostatins. , 2008, Nature chemical biology.

[48]  H. Ploegh,et al.  UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes , 2008, Nature.

[49]  K. Honda,et al.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.

[50]  B. Reizis,et al.  Notch–RBP-J signaling controls the homeostasis of CD8− dendritic cells in the spleen , 2007, The Journal of experimental medicine.

[51]  H. Ploegh,et al.  The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling , 2007, The Journal of cell biology.

[52]  V. Pascual,et al.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases. , 2006, Immunity.

[53]  M. Crow,et al.  Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. , 2006, Arthritis and rheumatism.

[54]  Zhengfan Jiang,et al.  Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. , 2006, Annual review of immunology.

[55]  S. Grinstein,et al.  The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9 , 2006, Nature Immunology.

[56]  S. Akira,et al.  RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement , 2005, The Journal of experimental medicine.

[57]  S. Akira,et al.  Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus , 2005, The Journal of experimental medicine.

[58]  M. Peterson,et al.  Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. , 2005, Arthritis and rheumatism.

[59]  A. Marshak‐Rothstein,et al.  Toll‐like receptors, endogenous ligands, and systemic autoimmune disease , 2005, Immunological reviews.

[60]  Y. Shoenfeld,et al.  Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. , 2004, Seminars in arthritis and rheumatism.

[61]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[62]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Shlomchik,et al.  Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.

[64]  S. Ju,et al.  Fas Ligand Engagement of Resident Peritoneal Macrophages In Vivo Induces Apoptosis and the Production of Neutrophil Chemotactic Factors1 , 2001, The Journal of Immunology.

[65]  S. Vogel,et al.  Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21 , 2000, The Journal of Immunology.

[66]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[67]  Stefan Grimm,et al.  The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal , 1998 .

[68]  C. Ware,et al.  TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. , 1998, Journal of immunology.

[69]  G. Kollias,et al.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response , 1996, The Journal of experimental medicine.

[70]  David D. Chaplin,et al.  Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal Centers , 1996, Science.

[71]  Y. Laouar,et al.  In vivo CD4+ lymph node T cells from lpr mice generate CD4-CD8-B220+TCR-beta low cells. , 1994, Journal of immunology.

[72]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[73]  R. Zinkernagel,et al.  Immune response in mice that lack the interferon-gamma receptor. , 1993, Science.

[74]  J. Hutcheson,et al.  Dendritic Cell Activation Limit RIPK1- and MyD88-Mediated Caspase-8 Acts as a Molecular Rheostat To , 2014 .

[75]  P. Leder,et al.  The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. , 1998, Immunity.